Associations of combined genetic and epigenetic scores with muscle size and muscle strength: a pilot study in older women

He, Lingxiao, Khanal, Praval, Morse, Chris I, Williams, Alun ORCID: https://orcid.org/0000-0002-8052-8184 and Thomis, Martine (2020) Associations of combined genetic and epigenetic scores with muscle size and muscle strength: a pilot study in older women. Journal of Cachexia, Sarcopenia and Muscle, 11 (6). pp. 1548-1561. ISSN 2190-5991

Preview

Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) | Preview

Abstract

Background: Inter-individual variance in skeletal muscle is closely related to genetic architecture and epigenetic regulation. Studies have examined genetic and epigenetic relationships with characteristics of ageing muscle separately, while no study has combined both genetic and epigenetic profiles in ageing muscle research. The aim of this study was to evaluate the association between combined genetic and methylation scores and skeletal muscle in older women. Methods: 48 older Caucasian women (aged 65–79 yr) were included in this study. Biceps brachii thickness and vastus lateralis anatomical cross-sectional area (ACSAVL) were measured by ultrasonography. Maximum isometric elbow flexion (MVCEF) and knee extension (MVCKE) torques were measured by a customized dynamometer. The muscle-driven genetic predisposition score (GPSSNP) was calculated based on seven muscle-related single nucleotide polymorphisms (SNPs). DNA methylation levels of whole blood samples were analysed using Infinium MethylationEPIC BeadChip arrays. The DNA methylation score was calculated as a weighted sum of methylation levels of sarcopenia-driven CpG sites (MSSAR) or an overall gene-wise methylation score (MSSNP, the mean methylation level of CpG sites located in muscle-related genes). Linear regression models were built to study genetic and epigenetic associations with muscle size and strength. Three models were built with both genetic and methylation scores: (1) MSSAR + GPSSNP, (2) MSSNP + GPSSNP, (3) gene-wise combined scores which were calculated as the ratio of the SNP score to the mean methylation level of promoters in the corresponding gene. Additional models with only a genetic or methylation score were also built. All models were adjusted for age and BMI. Results: MSSAR was negatively associated with ACSAVL, MVCEF and MVCKE, and explained 10.1%, 35.5% and 40.1% of the variance, respectively. MSSAR explained more variance in these muscular phenotypes than GPSSNP, MSSNP and models including both genetic and methylation scores. MSSNP and GPSSNP accounted for less than 8% and 5% of the variance in all muscular phenotypes, respectively. The genotype and methylation level of MSTN was positively related to MVCKE (p < 0.03) and explained 12.2% of the variance. The adjusted R2 and Akaike information criterion showed that models with only a MSSAR performed the best in explaining inter-individual variance in muscular phenotypes. Conclusion: Our results improve the understanding of inter-individual variance in muscular characteristics of older women and suggest a possible application of a sarcopenia-driven methylation score to muscle strength estimation in older women while the combination with a genetic score still needs to be further studied.